Market Place
Sourcing Support
Zetagen Therapeutics Completes Oversubscribed Series B1 Round
25 Nov 2025 //
BUSINESSWIRE
Zetagen to Present Promising Preclinical Data at SABCS
04 Nov 2025 //
BUSINESSWIRE
Zetagen Therapeutics To Unveil Phase 2 Trial Results
04 Nov 2025 //
BUSINESSWIRE
Zetagen Secures USPTO Patents for Novel Breast Cancer Platform
28 Jul 2025 //
BUSINESSWIRE
Zetagen Publishes ZetaMast Data in TNBC Liver Metastases
17 Jun 2025 //
BUSINESSWIRE
Zetagen Therapeutics Completes Enrollment in ZetaMet Phase 2a Study
06 May 2025 //
BUSINESSWIRE
Zetagen Expands IP With 64 Patents In 2024
08 Jan 2025 //
BUSINESSWIRE
Zetagen Shares In-vivo Dose Optimization Data for ZetaMAST™ in MBC
10 Dec 2024 //
BUSINESSWIRE
Zetagen Therapeutics Enrolls 1st Patients in ZetaMet™ Ph 2a Study
12 Nov 2024 //
BUSINESSWIRE
JAAOS Publishes Data on ZetaFuse® for Degenerative Disc Disease
24 Sep 2024 //
BUSINESSWIRE
Zetagen Announces Publication in Pain Management of Early Data Using ZetaMet
10 Oct 2023 //
BUSINESSWIRE
Zetagen Therapeutics Secures 9.79 Million USD Series B Funding Raise
11 Aug 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.